May 7, 2018 Acad, Gov/Utilities

FDA grants priority review to Roche’s cancer immunotherapy TECENTRIQ (atezolizumab) for initial treatment of people with a specific type of metastatic lung cancer

Basel, 07 May 2018 FDA grants priority review to Roche’s cancer immunotherapy TECENTRIQ (atezolizumab) for initial treatment of people with a specific type of metastatic lung cancer Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the US Food and Drug Administration (FDA) has accepted the company’s supplemental Biologics License Application (sBLA) and granted Priority... Read more

May 7, 2018 Acad, Gov/Utilities

FDA grants priority review to Roche’s cancer immunotherapy TECENTRIQ (atezolizumab) for initial treatment of people with a specific type of metastatic lung cancer

Basel, 07 May 2018 FDA grants priority review to Roche’s cancer immunotherapy TECENTRIQ (atezolizumab) for initial treatment of people with a specific type of metastatic lung cancer Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the US Food and Drug Administration (FDA) has accepted the company’s supplemental Biologics License Application (sBLA) and granted Priority... Read more

May 1, 2018 Acad, Gov/Utilities Liq. Handling & Robotics Product Launch

TAN/TBN titration in petrochemical samples – walk away automation for up to 112 samples

5/1/2018 Metrohm is pleased to present a fully automated solution for the determination of Total Acid Number (TAN) and Total Base Number (TBN) in up to 112 samples. This solution is based on the OMNIS Sample Robot and addresses the needs of QC laboratories in the petrochemical industry as well as contract laboratories looking for... Read more

April 30, 2018 Acad, Gov/Utilities

Californians remain concerned about future droughts; Support recycled water as a long-term solution for water security

SACRAMENTO, Calif.–(BUSINESS WIRE)–Apr. 30, 2018– Although 2017 brought significant rainfall to a dry state, Californians remain very concerned about future droughts, and the vast majority support using advanced technologies to generate new water supplies when needed. A statewide survey conducted in late 2017 found that an overwhelming majority of California residents believe another drought is... Read more

April 20, 2018 Acad, Gov/Utilities Bio/Pharma/CRO

QIAGEN announces FDA approval of PartoSure

Germantown, Maryland, and Hilden, Germany, April 20, 2018 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the U.S. regulatory approval of PartoSure®, which is a novel test for assessing the risk of spontaneous preterm birth in patients with symptoms of preterm labor. The pre-market approval of PartoSure by the U.S. Food and... Read more

April 18, 2018 Acad, Gov/Utilities Lab Top-10 Process Analytical Instr. Product Launch

New Online Sulfur Analyzer Enables Real-Time Data Analysis in the Oil and Gas Industry

New Online Sulfur Analyzer Enables Real-Time Data Analysis in the Oil and Gas Industry The next-generation Thermo Scientific SOLA iQ total sulfur analyzer is designed for process optimization and offers improved ease-of-use and connectivity over existing analyzers FRANKLIN, Mass., April 18, 2018 /PRNewswire/ — The new Thermo Scientific SOLA iQ online sulfur analyzer helps technicians, engineers... Read more

April 17, 2018 Acad, Gov/Utilities

FDA grants Breakthrough Therapy Designation for Roche’s Hemlibra in haemophilia A without inhibitors

Basel, 17 April 2018 FDA grants Breakthrough Therapy Designation for Roche’s Hemlibra in haemophilia A without inhibitors Designation based on phase III HAVEN 3 study demonstrating Hemlibra prophylaxis significantly reduced bleeds compared to no prophylaxis First medicine to show superior efficacy compared to prior factor VIII prophylaxis in an intra-patient comparison Roche (SIX: RO, ROG;... Read more

April 17, 2018 Acad, Gov/Utilities

FDA grants Breakthrough Therapy Designation for Roche’s Hemlibra in haemophilia A without inhibitors

Basel, 17 April 2018 FDA grants Breakthrough Therapy Designation for Roche’s Hemlibra in haemophilia A without inhibitors Designation based on phase III HAVEN 3 study demonstrating Hemlibra prophylaxis significantly reduced bleeds compared to no prophylaxis First medicine to show superior efficacy compared to prior factor VIII prophylaxis in an intra-patient comparison Roche (SIX: RO, ROG;... Read more

April 16, 2018 Acad, Gov/Utilities Bio/Pharma/CRO Chromatography Lab Top-10 Product Launch

Phenomenex Introduces bioZen Series for Characterization of Biotherapeutics

Torrance, Calif. (April 16, 2018) – Phenomenex Inc., a global leader in the research and manufacture of advanced technologies for the separation sciences, introduces bioZen – a new series of LC solutions for bioseparations in pharmaceutical, biopharmaceutical and academic research. The series encompasses both proven and entirely new media spanning two particle platforms – core-shell... Read more

April 16, 2018 Acad, Gov/Utilities Bio/Pharma/CRO M&A, Partnerships

Sartorius Stedim Biotech and Penn State University announce partnership

University Park, Pennsylvania, USA | Goettingen, Germany, April 16, 2018 – Sartorius Stedim Biotech and Penn State University have entered into a collaborative partnership to advance multidisciplinary teaching and research in biotechnology. This long-term relationship will support the education and preparation of the next generation of biotechnology leaders. Part of Sartorius’ investment will be to... Read more